MEDP
Medpace Holdings Inc
599.50$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +36.7% | -2.4% | -23.8% | +28.1% | +27.9% | -34.0% | +18.0% | +65.8% | -21.8% | -21.2% | +6.7% | – | |
| – | +1.4% | +0.3% | +3.5% | +3.9% | -0.2% | -7.7% | +1.2% | -9.6% | +12.5% | -3.2% | -2.8% | – | |
| – | +3.2% | -16.6% | -16.8% | +226.8% | -49.8% | +186.8% | -64.8% | +6.3% | -11.1% | -12.5% | -11.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +121.3% | -47.6% | -70.7% | +159.3% | +171.7% | -124.0% | – | +1,464.9% | -74.7% | -139.3% | – | – | |
| – | +14.7% | -45.0% | +134.1% | -18.1% | -27.5% | +30.8% | -38.8% | +163.5% | -71.8% | +50.2% | +250.9% | – | |
| – | -7.7% | – | -605.5% | -18.0% | -27.9% | +32.1% | -39.7% | +77.1% | -58.0% | +50.9% | +254.0% | – | |
| – | – | – | – | – | – | +118.9% | +45.4% | -99.2% | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +403.0% | -91.3% | +842.0% | -2,787.4% | +105.2% | +56.2% | – | +566.0% | -44.3% | -2,375.8% | – | |
| – | +168.0% | +7.5% | -35.7% | +40.5% | -91.4% | -1,918.8% | – | – | -11.4% | -26.5% | -196.4% | – | |
| – | +38.5% | +0.5% | -29.7% | +33.8% | +32.1% | -36.7% | +22.9% | +84.2% | -28.3% | -22.9% | -4.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.